Carrie C Lubitz

Summary

Publications

  1. ncbi request reprint Molecular analysis of minimally invasive follicular carcinomas by gene profiling
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Surgery 138:1042-8; discussion 1048-9. 2005
  2. pmc Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions
    Carrie C Lubitz
    Department of Surgery, Weill Cornell Medical College, Room A 983, 510 East 70th St, New York, NY 10021, USA
    J Mol Diagn 8:490-8; quiz 528. 2006
  3. ncbi request reprint Gene expression profiling of thyroid tumors--clinical applicability
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Nat Clin Pract Endocrinol Metab 2:472-3. 2006
  4. doi request reprint Identification of borderline thyroid tumors by gene expression array analysis
    Nimmi Arora
    Department of Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10065, USA
    Cancer 115:5421-31. 2009
  5. pmc BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence
    Jason D Prescott
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 2696, USA
    Surgery 152:984-90. 2012
  6. ncbi request reprint Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling
    David J Finley
    Department of Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Thyroid 15:562-8. 2005
  7. doi request reprint Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34
    Meredith A Kato
    Weill Medical College of Cornell University, New York, New York 10021, USA
    Nutr Cancer 62:66-73. 2010
  8. pmc Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy
    Sushruta S Nagarkatti
    Thyroid Cancer Laboratory, Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:60-5. 2013
  9. ncbi request reprint The differentiation of benign and malignant thyroid nodules
    Carrie C Lubitz
    Department of Surgery, New York Presbyterian Hospital, USA
    Adv Surg 39:355-77. 2005
  10. doi request reprint Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
    Surgery 148:1129-37; discussion 1137-8. 2010

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Molecular analysis of minimally invasive follicular carcinomas by gene profiling
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Surgery 138:1042-8; discussion 1048-9. 2005
    ..These studies were conducted to determine if molecular profiling can enhance our understanding of MIFTC and to perhaps offer a better classification schema...
  2. pmc Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions
    Carrie C Lubitz
    Department of Surgery, Weill Cornell Medical College, Room A 983, 510 East 70th St, New York, NY 10021, USA
    J Mol Diagn 8:490-8; quiz 528. 2006
    ..These results illustrate that microarray analysis of FNA is feasible and has the potential to improve the accuracy of FNA in categorizing benign from malignant lesions beyond routine cytological evaluation...
  3. ncbi request reprint Gene expression profiling of thyroid tumors--clinical applicability
    Carrie C Lubitz
    Department of Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Nat Clin Pract Endocrinol Metab 2:472-3. 2006
  4. doi request reprint Identification of borderline thyroid tumors by gene expression array analysis
    Nimmi Arora
    Department of Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10065, USA
    Cancer 115:5421-31. 2009
    ..A subset of follicular lesions of the thyroid is encapsulated similar to follicular adenomas but with partial nuclear features suggestive of papillary thyroid carcinoma (PTC), raising the possibility of biologically borderline tumors...
  5. pmc BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence
    Jason D Prescott
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 2696, USA
    Surgery 152:984-90. 2012
    ..No current risk classification system incorporates BRAF mutational status. Here, we assess the incremental value of BRAF mutational status in predicting PTC recurrence relative to existing recurrence risk algorithms...
  6. ncbi request reprint Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling
    David J Finley
    Department of Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Thyroid 15:562-8. 2005
    ..These studies were undertaken to determine whether benign follicular tumors could be subcategorized by molecular profiling...
  7. doi request reprint Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34
    Meredith A Kato
    Weill Medical College of Cornell University, New York, New York 10021, USA
    Nutr Cancer 62:66-73. 2010
    ..This is the first report of selenium induced inhibition of thyroid cancer cell growth...
  8. pmc Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy
    Sushruta S Nagarkatti
    Thyroid Cancer Laboratory, Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 20:60-5. 2013
    ..We sought to assess the characteristics and treatment of patients with an AUS/FLUS FNAB at our institution. Additionally, we evaluated the utility of the recommended 3-month timing of repeat FNAB...
  9. ncbi request reprint The differentiation of benign and malignant thyroid nodules
    Carrie C Lubitz
    Department of Surgery, New York Presbyterian Hospital, USA
    Adv Surg 39:355-77. 2005
  10. doi request reprint Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA
    Surgery 148:1129-37; discussion 1137-8. 2010
    ..We assessed the role of 4D-CT in patients with inconclusive preoperative ultrasound and sestamibi localization studies...
  11. doi request reprint Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms
    Carrie C Lubitz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Thyroid 20:25-31. 2010
    ..The aim of this study was to determine predictive characteristics of follicular neoplasms useful for clinical application...
  12. pmc Preoperative localization strategies for primary hyperparathyroidism: an economic analysis
    Carrie C Lubitz
    Endocrine Surgery Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Ann Surg Oncol 19:4202-9. 2012
    ..Strategies for localizing parathyroid pathology preoperatively vary in cost and accuracy. Our purpose was to compute and compare comprehensive costs associated with common localization strategies...